%PDF-1.3
3 0 obj
<>
endobj
4 0 obj
<>
stream
xU6+T([>U!$+$,im^5ieD
}f"Ig(;>% buTg*Tti藿O/ 鿙6.Cxǣ8^/ot3kMTrC~ݔW4Z~
<Ly
nv,ʕO\& 4ZQ˚)X82dzFۢVaY_GqE=1 y*N-@EAgԀՎ[_{O@B{ijW5!cu4s$-(m`PA48e^a14H?9,>R%&-2Yur )DrX T{!Z E=B7NMQv
-NLo]Y-ydBA4Wmxfg|Z9|YǦ#=KgI-1Xߴh~uSi_-UVɇRVk5sAr;h VՑQ{Xi͢Y#Np~N~;7r
endstream
endobj
1 0 obj
<>
endobj
5 0 obj
<>
endobj
2 0 obj
<<
/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]
/Font <<
/F1 5 0 R
>>
/XObject <<
>>
>>
endobj
6 0 obj
<<
/Producer (reterefit.com)
/Title (Karo Pharma Sweden Ab - Karo Pharma Strsta Aktiegare)
/Subject (Karo pharma sweden ab, karo pharma aktiebolag, karo pharma aktie forum, karo pharma annual report, karo pharma ab hlsovgen huddinge stockholms lnster, karo pharma sverige ab)
/Author (http://www.reterefit.com/index.php/karo-pharma-sweden-ab-aed1.pdf)
/Keywords (karo pharma ab hlsovgen huddinge stockholms lnster, karo pharma rights, karo pharma sweden ab, karo pharma strsta aktiegare)
/CreationDate (D:20190816163505)
>>
endobj
7 0 obj
<<
/Type /Catalog
/Pages 1 0 R
/OpenAction [3 0 R /FitH null]
/PageLayout /OneColumn
>>
endobj
xref
0 8
0000000000 65535 f
0000000981 00000 n
0000001166 00000 n
0000000009 00000 n
0000000087 00000 n
0000001068 00000 n
0000001270 00000 n
0000001809 00000 n
trailer
<<
/Size 8
/Root 7 0 R
/Info 6 0 R
>>
startxref
1912
%%EOF